Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic andā¦ read more
Healthcare
Biotechnology
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$176.92
Price-1.74%
-$3.13
1Y
Price
Market Cap
$10.751b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+20.9%
EBITDA Margin+22.3%
Net Profit Margin+40.8%
Free Cash Flow MarginRevenue
$4.158b
+2.2%
1y CAGR+4.4%
3y CAGR+7.8%
5y CAGREarnings
-$368.484m
-165.8%
1y CAGR+51.5%
3y CAGR+46.6%
5y CAGREPS
-$6.07
-170.2%
1y CAGR+47.3%
3y CAGR+44.3%
5y CAGRBook Value
$3.959b
$11.356b
Assets$7.397b
Liabilities$5.429b
DebtDebt to Assets
47.8%
21.1x
Debt to EBITDAFree Cash Flow
$1.337b
-0.8%
1y CAGR+21.1%
3y CAGR+17.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company